Matthew P. Kowalsky
Chief Administrative Officer chez SIGILON THERAPEUTICS, INC.
Fortune : - $ au 31/07/2023
Profil
Matthew P.
Kowalsky is currently the Secretary & Chief Legal Officer at Sigilon Therapeutics, Inc. He previously worked as Assistant General Counsel at ARIAD Pharmaceuticals, Inc. and Lantheus Medical Imaging, Inc. He also worked as Associate General Counsel at Cubist Pharmaceuticals LLC and Senior Corporate Counsel at Genzyme Corp.
Before joining Sigilon Therapeutics, Inc., he was the Secretary & Vice President-Legal at Proteon Therapeutics, Inc. Mr. Kowalsky received his undergraduate degree from the University of Notre Dame and his graduate degree from the University of Notre Dame The Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/08/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Postes actifs de Matthew P. Kowalsky
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Administrative Officer | - |
Anciens postes connus de Matthew P. Kowalsky
| Sociétés | Poste | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | General Counsel | 01/01/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/05/2016 |
| CUBIST PHARMACEUTICALS INC | General Counsel | 01/01/2015 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 01/11/2013 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | General Counsel | 01/01/2013 |
Formation de Matthew P. Kowalsky
| University of Notre Dame | Undergraduate Degree |
| University of Notre Dame The Law School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
